Mason Street Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-30,268
Closed -$187K 1524
2018
Q3
$187K Buy
30,268
+769
+3% +$3.48K ﹤0.01% 1395
2018
Q2
$188K Buy
29,499
+1,161
+4% +$8.26K ﹤0.01% 1390
2018
Q1
$198K Buy
28,338
+1,769
+7% +$20.6K ﹤0.01% 1343
2017
Q4
$335K Buy
26,569
+363
+1% +$4.43K 0.01% 1170
2017
Q3
$311K Buy
26,206
+1,052
+4% +$15.6K 0.01% 1179
2017
Q2
$377K Buy
25,154
+1,739
+7% +$23.2K 0.01% 1084
2017
Q1
$223K Buy
23,415
+1,398
+6% +$11.8K 0.01% 1238
2016
Q4
$195K Buy
22,017
+1,176
+6% +$10.6K 0.01% 1267
2016
Q3
$179K Buy
20,841
+1,353
+7% +$10.7K 0.01% 1242
2016
Q2
$156K Buy
19,488
+2,048
+12% +$15.9K ﹤0.01% 1249
2016
Q1
$152K Buy
17,440
+1,459
+9% +$12.1K ﹤0.01% 1225
2015
Q4
$150K Buy
15,981
+1,380
+9% +$12K ﹤0.01% 1203
2015
Q3
$141K Buy
14,601
+1,534
+12% +$16.2K ﹤0.01% 1189
2015
Q2
$151K Buy
+13,067
New +$134K ﹤0.01% 1192

Other funds holding MDXG

Mason Street Advisors's MDXG Position: Q4 2018 in Review

Mason Street Advisors sold out of MiMedx Group (MDXG) in Q4 2018, closing a stake of 30,268 shares — an estimated $187K sold.

Mason Street Advisors first reported a position in MDXG in Q2 2015 and held it in 14 quarters. The position peaked at $377K in Q2 2017. 38 funds tracked by Wall St. Rank hold MDXG as of Q4 2018.

  • Mason Street Advisors reported no remaining MiMedx Group position as of Q4 2018 after selling out during the quarter.
  • Mason Street Advisors sold 30,268 MiMedx Group shares in Q4 2018, an estimated $187K.
  • Mason Street Advisors first reported a position in MiMedx Group in Q2 2015 and held it in 14 quarters.
  • Mason Street Advisors's MiMedx Group position peaked at $377K in Q2 2017.
  • 38 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2018.

Based on Mason Street Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.